Trospium

Resumen

Alternativas con registro en Colombia

• Flavoxato · costo anual estimado $ 594.585
• Oxibutinina · costo anual estimado $ 267.180
• Tolterodina · costo anual estimado $ 523.775
• Solifenacina · costo anual estimado $ 448.220
• Darifenacina · costo anual estimado $ 675.615
• Mirabegron · costo anual estimado $ 778.910
• Imidafenacina

Estudios clínicos principales

• ARISE: A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
  Fase 3 · 2021 · 396 participantes · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05145413
• A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)
  Fase 3 · 2021 · 256 participantes · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT04738123
• A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2)
  Fase 3 · 2020 · 252 participantes · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT04659161
• UNITE-001: A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia
  Fase 3 · 2023 · 202 participantes · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05919823

Enfermedades relacionadas

• Incontinencia y vejiga hiperactiva

Fuentes

• Etiqueta FDA (DailyMed): Trospium Chloride
• Resolución INVIMA 2024008475